Literature DB >> 17569796

Will generic hypertension guidelines reduce the proliferation of directives?

Jan A Staessen, Eoin O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17569796      PMCID： PMC1994463          DOI： 10.1136/hrt.2006.109512

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  17 in total

1.  Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias.

Authors:  Jonathan R Emberson; Peter H Whincup; Richard W Morris; Mary Walker
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

2.  Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.

Authors:  Eoin O'Brien; Roland Asmar; Lawrie Beilin; Yutaka Imai; Giuseppe Mancia; Thomas Mengden; Martin Myers; Paul Padfield; Paolo Palatini; Gianfranco Parati; Thomas Pickering; Josep Redon; Jan Staessen; George Stergiou; Paolo Verdecchia
Journal:  J Hypertens       Date:  2005-04       Impact factor: 4.844

Review 3.  Blood pressure lowering for primary and secondary prevention of stroke.

Authors:  Haifeng Zhang; Lutgarde Thijs; Jan A Staessen
Journal:  Hypertension       Date:  2006-07-03       Impact factor: 10.190

4.  Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Roberto Gattobigio; Maurizio Bentivoglio; Lutgarde Thijs; Jan A Staessen; Carlo Porcellati
Journal:  Hypertension       Date:  2005-07-11       Impact factor: 10.190

5.  Multiple biomarkers for the prediction of first major cardiovascular events and death.

Authors:  Thomas J Wang; Philimon Gona; Martin G Larson; Geoffrey H Tofler; Daniel Levy; Christopher Newton-Cheh; Paul F Jacques; Nader Rifai; Jacob Selhub; Sander J Robins; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2006-12-21       Impact factor: 91.245

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

8.  Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.

Authors:  F Turnbull; B Neal; M Pfeffer; J Kostis; C Algert; M Woodward; J Chalmers; A Zanchetti; S MacMahon
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

9.  Adverse prognostic significance of new diabetes in treated hypertensive subjects.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Claudia Borgioni; Roberto Gattobigio; Lucia Filippucci; Silvia Norgiolini; Costanza Bracco; Carlo Porcellati
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

Review 10.  Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Authors:  Juan P Casas; Weiliang Chua; Stavros Loukogeorgakis; Patrick Vallance; Liam Smeeth; Aroon D Hingorani; Raymond J MacAllister
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321
View more
  1 in total

1.  Irbesartan/Hydrochlorothiazide : in moderate to severe hypertension.

Authors:  Jamie D Croxtall; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.